Table 1 CHHIP trial based clinical planning goals for IA and IB
ROI Name | Dose Parameter | Goal |
|---|---|---|
Target and Max Dose Goals | ||
All PTVs | D99% | ≥ 95% of PTV prescription |
PTV57.5 - PTV60 | D50% | ≥ 57.5 Gy |
PTV48 - PTV57.5 | D50% | ≥ 48 Gy |
PTV60 | D1% | ≤ 63.0 Gy |
Patient Outline | D1.8 cm3 | ≤ 63.0 Gy |
OAR Goals | ||
Rectum | V24.3 Gy | ≤ 80% |
Rectum | V32.4 Gy | ≤ 70% |
Rectum | V40.5 Gy | ≤ 60% |
Rectum | V48.6 Gy | ≤ 50% |
Rectum | V52.7 Gy | ≤ 30% |
Rectum | V56.8 Gy | ≤ 15% |
Rectum | V60.0 Gy | ≤ 3% |
Bladder | V40.5 Gy | ≤ 50% |
Bladder | V48.6 Gy | ≤ 25% |
Bladder | V60.0 Gy | ≤ 5% |
Femoral Heads | V40.5 Gy | ≤ 50% |
Bowel | V40.5 Gy | ≤ 17 cm3 |